期刊文献+

Oct4在多种人腺癌组织中表达水平的研究 被引量:3

Research the expression of Oct4 in multiple adenocarcinoma
下载PDF
导出
摘要 目的:研究5种人腺癌中Oct4的表达情况,为进一步探索其在肿瘤发生中的机制提供基础。方法:应用乳腺癌、胃癌、胰腺癌、肠癌、子宫内膜癌5种腺癌的组织芯片,通过免疫组织化学染色研究Oct4蛋白在组织中的表达情况,并与癌旁正常组织进行比较。结果:Oct4在5种腺癌肿瘤组织内均有表达,胃癌组织内Oct4的表达高于癌旁正常组织(P<0.05),其他腺癌组织中Oct4的表达与癌旁组织差异无统计学意义;在乳腺癌和肠癌中,无淋巴结转移患者的肿瘤组织中Oct4表达高于淋巴结转移患者的肿瘤组织(P<0.05),而在胃癌、胰腺癌及子宫内膜癌患者中未观察到这种差异;5种腺癌的肿瘤组织内,未发现Oct4的表达与临床分期有关。Oct4在癌旁正常组织中(子宫内膜癌除外)主要定位于细胞浆,而在腺癌组织中既表达于细胞核,也表达于细胞浆。结论:Oct4的表达可能是肿瘤发生过程中的早期事件,不同腺癌组织中Oct4的表达情况不完全相同,Oct4的核/浆表达模式可能与其在肿瘤发生中的作用有关。 Objective: To study the expression of Oct4 in adenocarcinomas from 5 tissue origins and provide insights to the Oct4-related mechanism of carcinogensis. Methods: Immuno-histochemistry staining was adopted to study the expression of Oct4 protein in adenocareinoma tissue array containing adenocarcinoma and paratumoral samples of 5 tissue origins. Results: Oct4 was expressed in all 5 adenocarcinomas. Oct4 was significantly differently expressed in gastric-derived adenocarcinoma and paratumoral tissue (P〈0.05), but not other origins. Breast and intestinal adenocarcinomas without lymph riode metastasis had stronger Oct4 expression than those with lymph node metastasis (P〈0.05). However, there was no dif- ference of Oct4 level in gastric cancer, pancreatic cancer and endometrial cancer, no association of Oct4 expression with clinical stage was observed. Except for in endometrium tissue, Oct4 was mainly located in cytoplasm in normal tissue, but in nucleus and cytoplasm in tumor tissue. Conclusion: The expression of Oct4 may be an early event during tumorigenesis; Oct4 was expressed in different patterns in various tissues and their counterpart adenocarcinoma. The distribution of Oct4 in nuclear or cytoplasm may present its physiolozical or pathological function during tumorigenesis.
出处 《中国医药导报》 CAS 2011年第8期17-20,共4页 China Medical Herald
基金 国家自然科学基金面上项目(30973447)
关键词 OCT4 腺癌 组织芯片 免疫组织化学 Oct4 Adenocarcinoma Tissue array Immuno-histochemistry
  • 相关文献

参考文献20

  • 1Hochedlinger K, Yamada Y, Beard C, et al. Ectopic expression of OCT- 4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues [J]. Ce11,2005,121(3):465-477.
  • 2Gidekel S, Pizov G, Bergman Y, et al. Oct-3/4 is a dose-dependent oncogenic fate determinant [J]. Cancer Ce11,2003,4:361-370.
  • 3Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells [J]. PLoS ONE,2008,3(7):e2637.
  • 4马晓艳,张蕾,高冬玲,赵阿红,陶识博,陈妍琼.MTA1与E-cadherin在乳腺癌中的表达及临床意义[J].肿瘤基础与临床,2009,22(2):103-105. 被引量:6
  • 5Pesce M, Schhler HR. Oct-4: control of totipotency and germline dete- rmination [J]. Mol Reprod Dev,2000,55(4):452-457.
  • 6Okuda T, Tagawa K, Qi ML, et al. Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo [J]. Mol Brain Res,2004,132( 1): 18-30.
  • 7Zaehres H, Scholer HR. Induction of pluripotency: from mouse to human [J]. Ce11,2007,131 (5):834-835.
  • 8Kim JB, Sebastiano V, Wu GM, et al. Oct4-induced pluripotency in adult neural stem cells [J]. Ce11,2009,136(3):663-676.
  • 9Looijenga LH, Stoop H, de Leeuw HP, et al. POU5FI (0CT3/4) identifies cells with pluripotent potential in human germ cell tumors [J]. Cancer Res,2003,63 (9):2244-2250.
  • 10Atlasi Y, Mowla SJ, Ziaee SA, et al. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer [J]. Int J Cancer, 2007,120(7): 1598-1602.

二级参考文献4

共引文献5

同被引文献36

  • 1李秀娟,金春亭,范婕,李玉珍,李海军,刘军超.Oct4和Wnt1在食管鳞癌中的表达及其相关性[J].中国老年学杂志,2014,34(10):2631-2632. 被引量:2
  • 2Junko Matsuoka,Masakazu Yashiro,Katsunobu Sakurai,Naoshi Kubo,Hiroaki Tanaka,Kazuya Muguruma,Tetsuji Sawada,Masaichi Ohira,Kosei Hirakawa.Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma[J].Journal of Surgical Research.2012(1)
  • 3W.F. van der Meide,S. Snellenberg,C.J.L.M. Meijer,A. Baalbergen,T.J.M. Helmerhorst,W.B. van der Sluis,P.J.F. Snijders,R.D.M. Steenbergen.Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix[J].Gynecologic Oncology.2011(1)
  • 4Jeong TaeDo,Hans R.Sch?ler.Nuclei of Embryonic Stem Cells Reprogram Somatic Cells[J].STEM CELLS.2008(6)
  • 5R.M Bright-Thomas,R Hargest.APC, β-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer[J].European Journal of Surgical Oncology.2003(2)
  • 6Faunes F,Hayward P,Descalzo SM,et al.Amembrane-associatedβ-catenin/Oct4 complex correlateswith ground-state pluripotency in mouse embryonic stemcells[].Development.2013
  • 7Nelson W J,Nusse R.Convergence of Wnt, beta-catenin, and cadherin pathways[].Science.2004
  • 8Xueyan Zhang,Baohui Han,Jinsu Huang,Biqiang Zheng,Qin Geng,Fahad Aziz,Qianggang Dong.Prognostic Significance of OCT4 Expression in Adenocarcinoma of the Lung[].Japanese Journal of Clinical Oncology.2010
  • 9Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer[].Oncology.2000
  • 10Chen Cai,Xiaohan Zhu.The Wnt/beta-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer[].MOLECULAR MEDICINE REPORTS.2012

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部